Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
about
Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samplesEvaluation of paired-end sequencing strategies for detection of genome rearrangements in cancerMTA1, a transcriptional activator of breast cancer amplified sequence 3Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA ampliconsTopHat-Fusion: an algorithm for discovery of novel fusion transcriptsPrognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs)Genomic interaction profiles in breast cancer reveal altered chromatin architecture.A sequence-based survey of the complex structural organization of tumor genomes.Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencingGAP-Seq: a method for identification of DNA palindromes.The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genomeGenome-wide significant localization for working and spatial memory: Identifying genes for psychosis using models of cognition.New methods as alternative or corrective measures for the pitfalls and artifacts of reverse transcription and polymerase chain reactions (RT-PCR) in cloning chimeric or antisense-accompanied RNALong-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell linesDecoding the fine-scale structure of a breast cancer genome and transcriptome.Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes.FusionQ: a novel approach for gene fusion detection and quantification from paired-end RNA-SeqTranscriptional consequences of genomic structural aberrations in breast cancer.A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell linesChromosome-breakage genomic instability and chromothripsis in breast cancerConstruction of mate pair full-length cDNAs libraries and characterization of transcriptional start sites and termination sites.Genome-wide association analysis identifies three new risk loci for gout arthritis in Han Chinese.Identifying critical differentiation state of MCF-7 cells for breast cancer by dynamical network biomarkers.Renal cell neoplasms contain shared tumor type-specific copy number variations.Characterization of fusion genes and the significantly expressed fusion isoforms in breast cancer by hybrid sequencing.PAR6B is required for tight junction formation and activated PKCζ localization in breast cancerNCLscan: accurate identification of non-co-linear transcripts (fusion, trans-splicing and circular RNA) with a good balance between sensitivity and precisionMulticolour-banding fluorescence in situ hybridisation (mbanding-FISH) to identify recurrent chromosomal alterations in breast tumour cell lines.Lessons learned from the initial sequencing of the pig genome: comparative analysis of an 8 Mb region of pig chromosome 17.Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes.Characterization of breast cancer by array comparative genomic hybridization.Low Doses of Cisplatin Induce Gene Alterations, Cell Cycle Arrest, and Apoptosis in Human Promyelocytic Leukemia CellsGene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer.Chimeric transcript discovery by paired-end transcriptome sequencingFinding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databasesNuclear receptor coregulators in cancer biology.RWCFusion: identifying phenotype-specific cancer driver gene fusions based on fusion pair random walk scoring method.Fusion gene microarray reveals cancer type-specificity among fusion genes.A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
P2860
Q21092937-3B3AB5AE-F99F-4E28-A5EF-0797D702C1E4Q21145383-0CDC1C2C-A3D2-4B97-9892-F39D39FFDC39Q24546715-D846D8DB-9508-48CC-83E5-859D48CA1D78Q24799947-EB208526-6ACE-400B-B856-2446ECEF8929Q27499675-86FE2953-0B3E-48CF-BA0D-7F4CDFE5EA8EQ27852024-E05F7D76-C604-4C37-BB07-BE1247E262BEQ28757561-2D6D48AE-6300-4B97-992C-FA5BB0C65E49Q31137734-C8786B06-24EF-4D7D-B7AB-6E86F6CA82A9Q33325344-94E7B376-D5E4-4290-9F6A-175197C2318AQ33534062-BE95A4E8-1D8A-4F34-91AB-4E629A06E67BQ33755253-E8FD3FEB-E55C-4977-ADEB-9795D55BC2EBQ33805565-2A9526C8-7CC7-413A-B0DA-B096003193BFQ33930490-837739AF-6BC1-40AB-BAE0-F77EAAE1599EQ33953031-8F21A799-09E0-4A6A-ADFA-5BFA7915CC57Q34036642-930931C2-65A0-43F4-8164-EB1FEA7D1C26Q34483093-2368D94D-78E3-4912-952E-C93E77C9CFB3Q34520381-B29E775D-0C51-4371-947F-6322DA769973Q34773807-3222C7F7-7A3C-492E-8437-AF5313AF5665Q34867822-D9DB7665-3B32-47F2-B9E9-2B580E41B718Q35174790-06460BBD-3C98-4625-A0E8-F8806620FCE4Q35204806-AC6005E6-ADF6-489E-9199-56EEA9951445Q35208578-B1AE26DD-7D68-4D86-9B80-17263E67ED18Q35775398-8A9EE743-C43A-4E91-8687-A7A866A05179Q35894877-A580EC8A-283B-42BC-BF44-090D0C55B574Q36044617-FC890C57-B9F0-4644-B747-985DCE97FE49Q36160576-ECB927C3-476C-4C09-AFD5-D6BA607D5C97Q36206503-54BC957F-6208-47A8-8A8B-107E531B3384Q36588864-7A4D87AB-8F63-4841-942D-2FEE87FB43D8Q36616101-7515143B-E274-4536-AB6D-E613281BCF41Q36643123-74242361-DB62-408A-BC3F-40ED49AEB656Q36710467-B99703B2-8D43-4FB2-9B2E-674298F764BAQ36916665-8AD0FE23-C379-4B07-B430-7776AFA375EDQ37204356-52C0AC96-9AB8-4049-B3DC-B59479E117CAQ37248141-3FFB0AA7-BFA2-427D-BCF8-67320A9DC035Q37257656-E898DEE0-8C72-4006-A90D-42C2B569AE35Q37513054-BD5D75B6-7D83-44C6-89E9-80F8F1C2F4F5Q37618468-81857A7E-5F4B-47AA-8322-61C7E88E60B5Q37641558-30A33A7F-9CE0-4789-A0F9-DFA3D5373738Q39595452-4F34360C-E01F-4E87-AA13-CC87FD437211Q40640693-DB24608D-556B-442B-9FBE-DC516F2EF591
P2860
Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cloning of BCAS3 (17q23) and B ...... , and fusion in breast cancer.
@ast
Cloning of BCAS3 (17q23) and B ...... , and fusion in breast cancer.
@en
Cloning of BCAS3 (17q23) and B ...... , and fusion in breast cancer.
@nl
type
label
Cloning of BCAS3 (17q23) and B ...... , and fusion in breast cancer.
@ast
Cloning of BCAS3 (17q23) and B ...... , and fusion in breast cancer.
@en
Cloning of BCAS3 (17q23) and B ...... , and fusion in breast cancer.
@nl
prefLabel
Cloning of BCAS3 (17q23) and B ...... , and fusion in breast cancer.
@ast
Cloning of BCAS3 (17q23) and B ...... , and fusion in breast cancer.
@en
Cloning of BCAS3 (17q23) and B ...... , and fusion in breast cancer.
@nl
P2093
P2860
P356
P1476
Cloning of BCAS3 (17q23) and B ...... , and fusion in breast cancer.
@en
P2093
Guido Sauter
J Donald Weaver
Maarit Bärlund
Mervi Heiskanen
Olli-P Kallioniemi
Outi Monni
Päivikki Kauraniemi
P2860
P304
P356
10.1002/GCC.10121
P577
2002-12-01T00:00:00Z